Agent and product for the diagnosis and treatment of tumors and for the treatment of weaknesses of the cellular and humoral immune defense
OwnerUdo Ehrenfeldinventor
Life of this patent
Estimating the term…
Abstract
An agent for the diagnosis and treatment of malignant tumors and for the treatment of lowered cellular and humoral immune defense is described which contains an immune modulator, a lipopolysaccharide or an immune modulator tagged with a radioactive tracer, a dyestuff or a cytostatic, or a similar polysaccharide, possibly in and/or on liposomes or lipidized. There is also described a product which contains the agent together with an adjuvant consisting of an aldehyde and an alcohol. There is also described a method for the diagnosis of malignant tumors comprising the step of administering to a mammal a diagnostic effective amount of the agent, optionally together with an adjuvant consisting of an aldehyde and an alcohol.
Claims14
An agent for the diagnosis and treatment of malignant tumors and for the treatment of reduced cellular and humoral immune defense, comprising a pharmaceutical carrier and an a immune modulator which is an extract from bacteria or a mixture of bacteria extracts, wherein the bacteria are selected from the group consisting of Norcardia rubra, Nocardia opaca, Calmette-Guerin bacillus and salmonella, and which immune modulator is (1) tagged with a radioactive tracer, dyestuff or cytostatic or a mixture of such tagged immune modulators, or (2) tagged with a radioactive tracer, dyestuff or cytostatic or a mixture of such tagged immune modulators or tagged with tin-II-chloride (a) in and on liposomes or (b) in or on liposomes or (c) lipidized.
Dependencies are inferred from the claim text.